Biotechnology Value Fund II LP

InsiderAllakos Inc. (ALLK) · full profile →Form 4 · filed May 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2025Disposed to issuer(D)855K0
May 15, 2025Disposed to issuer(D)8.7M0
May 15, 2025Disposed to issuer(D)6.8M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-001590) within minutes of acceptance. Every field above traces to the original document. Verify it directly: